Results 211 to 220 of about 424,438 (249)

Drug costs for patients with Parkinson's disease in two different European countries

Acta Neurologica Scandinavica, 2006
Corinna Vossius, H Baas, Jan Petter Larsen   +2 more
exaly  

The Cost of Drug Research

Royal Society of Health Journal, 1975
openaire   +2 more sources

The Financial and Environmental Costs of Reusable and Single-Use Plastic Anaesthetic Drug Trays

Anaesthesia and Intensive Care, 2010
Forbes Mcgain, David Story
exaly  

Drug Development Costs

The Journal of Clinical Pharmacology, 1987
openaire   +2 more sources

Intensive care unit drug costs in the context of total hospital drug expenditures with suggestions for targeted cost containment efforts

Journal of Critical Care, 2018
Shoroq M Altawalbeh, Melissa I Saul, Amy L Seybert   +2 more
exaly  

Is Bariatric Surgery Effective in Reducing Comorbidities and Drug Costs? A Systematic Review and Meta-Analysis

Obesity Surgery, 2015
Airton Tetelbom Stein
exaly  

Drug costs.

Lancet (London, England), 1976
openaire   +3 more sources

Drug repurposing: progress, challenges and recommendations

Nature Reviews Drug Discovery, 2018
Sudeep P Pushpakom, Francesco Iorio, Patrick A Eyers   +2 more
exaly  

Economic analysis of costs and consequences of the treatment of drug misuse: 2‐year outcome data from the National Treatment Outcome Research Study (NTORS)

Addiction, 2004
Christine Godfrey, Duncan Stewart, Michael Gossop   +2 more
exaly  

Drug and treatment costs in Parkinson’s disease patients in Sweden

Acta Neurologica Scandinavica, 2012
Sixten Borg, Ulf Persson, Gunnar Ljunggren   +2 more
exaly